SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Multi Country Contract with Rentokil

20 Jul 2011 07:00

RNS Number : 6939K
Byotrol PLC
20 July 2011
 



 20 July 2011

 

 

Byotrol plc

Four Year, Multi Country, Multi Product agreement

with Rentokil Initial plc

 

 

Byotrol plc ('Byotrol'), the developer of anti microbial hygiene technologies, is delighted to announce that it has signed a potentially multi-million pound contract, with Rentokil Initial plc ('Rentokil'). The four year contract covers multiple countries and a range of products.

 

This potentially transformational deal represents a landmark commercial milestone for Byotrol. The Byotrol technology will be adopted by the Initial Hygiene division ('Initial') of Rentokil, one of the largest business services companies in the world, providing hygiene services to a range of clients including Government, health and education and commercial organisations.

 

The contract is for the supply of hand hygiene and surface sanitisation products for use in Initial's service offering to washrooms and kitchens across 16 European countries. This contract confirms Byotrol's unique anti microbial technology as the innovation of choice for companies looking to the next generation of hygiene solution.

 

The products and services based on the Byotrol technology platform will be rolled out by Initial starting in Q4 2011, and will see Byotrol positioned as an important ingredient within Initial's hand hygiene product portfolio.

 

Commenting on the contract, Gary Millar, CEO of Byotrol, said:

 

"Our strategy of working with specialist service suppliers and distributors is borne out by this significant contract. The endorsement of the Byotrol technology by the Initial Hygiene division of Rentokil is tremendously exciting, and will transform the way Byotrol's technology is recognised in the hygiene industry. Additionally, Rentokil's ability to deploy the technology into wider markets will significantly extend the number of those brought into contact with Byotrol."

Peter Slator, Business Manager, Rentokil's Initial Hygiene business unit, added:

 

"Our new range of surface and hand hygiene products, powered by Byotrol's unique technology, will be a valuable element in achieving Initial's objective of 'Raising Hygiene Standards' throughout our customers' organisations. With its gentle, yet powerful, formulation and its long lasting antimicrobial properties, it will give our customers access to a pioneering hygiene solution and enable us to penetrate new markets."

 

 

Enquiries:

 

Byotrol plc 01925 742 000

Gary Millar, Chief Executive

Richard Bell, Finance Director

 

Arbuthnot Securities 020 7012 2000

Nominated Adviser and broker

Antonio Bossi / Henry Willcocks

 

Winningtons 020 3176 4722

Tom Cooper / Paul Vann 0797 122 1972

 

 

Notes to Editors:

 

Byotrol plc (BYOT.L), quoted on AIM, is a leading microbial technology hygiene company, operating globally in the Health, Food, Leisure, Consumer, Industrial and Agriculture sectors, providing a low toxicity product with a broad-based and long lasting efficacy across all microbial classes; bacteria, viruses, fungi, moulds, microbacteria and algae.

 

The Byotrol product can be used as a standalone product or as a complementary biocide additive to existing products to improve their performance in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.

 

Founded in 2005, the Company has prioritised the development of a technology that creates easier, safer and cleaner lives through partnering with providers of essential goods and services. Byotrol is the catalyst behind the aptly named global 'Hygiene Revolution'.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTMMGMNLLVGMZM
Date   Source Headline
21st May 20267:00 amRNSAppointment of CEO, North America
8th May 202610:30 amRNSHolding(s) in Company
7th May 20264:40 pmRNSResult of AGM
23rd Apr 20264:25 pmRNSFinal Dividend – Pence Sterling Amount Payable
23rd Apr 20262:30 pmRNSIssuance of $500 million 4.625% Notes due 2031
21st Apr 202610:30 amRNSHolding(s) in Company
16th Apr 20267:00 amRNSQ1 Trading Update
15th Apr 20267:00 amRNSDirectorate Change
30th Mar 202610:30 amRNSHolding(s) in Company
26th Mar 20263:46 pmRNSDirector/PDMR Shareholding
25th Mar 202610:50 amRNSAnnual Financial Report
17th Mar 20264:30 pmRNSDirector/PDMR Shareholding
16th Mar 202610:32 amRNSHolding(s) in Company
16th Mar 202610:32 amRNSHolding(s) in Company
12th Mar 202610:30 amRNSHolding(s) in Company
10th Mar 20264:28 pmRNSDirector/PDMR Shareholding
10th Mar 20264:28 pmRNSDirector/PDMR Shareholding
10th Mar 20264:26 pmRNSDirector/PDMR Shareholding
10th Mar 20264:26 pmRNSDirector/PDMR Shareholding
9th Mar 202611:15 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSPreliminary Results
5th Mar 20267:00 amRNSChair Succession Planning Update
23rd Feb 202610:30 amRNSHolding(s) in Company
19th Feb 20262:50 pmRNSDirector Declaration
12th Feb 20265:30 pmRNSNotice of Early Redemption
20th Jan 202610:25 amRNSHolding(s) in Company
19th Jan 202610:30 amRNSHolding(s) in Company
16th Jan 20263:00 pmRNSHolding(s) in Company
14th Jan 202610:30 amRNSHolding(s) in Company
13th Jan 202610:30 amRNSHolding(s) in Company
13th Jan 20267:00 amRNSDirectorate change
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
5th Dec 202510:30 amRNSHolding(s) in Company
5th Dec 202510:30 amRNSHolding(s) in Company
26th Nov 20254:25 pmRNSHolding(s) in Company
28th Oct 202510:45 amRNSHolding(s) in Company
28th Oct 202510:45 amRNSHolding(s) in Company
27th Oct 202510:30 amRNSHolding(s) in Company
23rd Oct 202511:45 amRNSHolding(s) in Company
23rd Oct 20257:00 amRNSQ3 Trading Update
21st Oct 202510:00 amRNSHolding(s) in Company
14th Oct 202510:00 amRNSHolding(s) in Company
1st Oct 202510:30 amRNSBlock listing Interim Review
30th Sep 202510:30 amRNSCompletion of France Workwear business sale
25th Sep 20254:15 pmRNSDirector/PDMR Shareholding
24th Sep 20256:00 pmRNSDirector Declaration
26th Aug 202512:30 pmRNSInterim Dividend – Pence Sterling Amount Payable
7th Aug 202511:10 amRNSHolding(s) in Company
31st Jul 20257:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.